Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Insulet Corporation - Common Stock (NQ:PODD)

322.22 -9.91 (-2.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Why Insulet (PODD) Shares Are Falling Today
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 4.3% in the morning session after the company announced a change in its chief financial officer, a move that appeared to... 
Via StockStory
Topics Economy
Tech Stocks Slip, Small Caps Soar Ahead Of Fed Rate Decision: What's Moving Markets Wednesday?
Small-cap and blue-chip stocks advanced in Wednesday morning trading on Wall Street, while technology names lagged and the S&P 500 hovered near record levels as investors braced for the Federal... 
Via Benzinga
Topics Economy
Top S&P500 movers in Wednesday's session
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Is the Market Bullish or Bearish on Insulet?
 
Via Benzinga
Gapping S&P500 stocks in Wednesday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Insulet Announces CFO Transition
From Insulet Corporation
Via Business Wire
3 Reasons Investors Love Insulet (PODD)
Insulet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 18%. The stock now trades at $337, marking a 35.7% gain. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
Which S&P500 stocks are moving on Wednesday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
These S&P500 stocks are gapping in today's session
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
Insulet Corp (NASDAQ:PODD) Combines Technical Strength and Fundamental Momentum for High-Growth Potential
Insulet Corp (PODD) combines strong technical uptrends with accelerating earnings and revenue growth, making it a top high-growth momentum stock. 
Via Chartmill
3 S&P 500 Stocks to Target This Week
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
Assessing Insulet: Insights From 6 Financial Analysts
 
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
2 Mid-Cap Stocks Worth Your Attention and 1 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
3 Cash-Producing Stocks to Target This Week
Cash-generating companies often have the flexibility to invest, return capital to shareholders, or navigate downturns. The best of these businesses not only accumulate cash but deploy it strategically... 
Via StockStory
Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers. 
Via StockStory
Topics Artificial Intelligence
Insulet Elevates Eric Benjamin to Chief Operating Officer
From Insulet Corporation
Via Business Wire
2 Surging Stocks with Exciting Potential and 1 We Brush Off
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
2 Growth Stocks to Add to Your Roster and 1 Facing Headwinds
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
Demystifying Insulet: Insights From 7 Analyst Reviews
 
Via Benzinga
Cisco, Rocket Companies, Insulet And More On CNBC's 'Final Trades'
Lending support to his choice, BTIG analyst initiated coverage on Rocket Companies with a Buy rating and $25 price target. Cisco and Insulet also discussed. 
Via Benzinga
Insulet to Participate in Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Here's How Much You Would Have Made Owning Insulet Stock In The Last 15 Years
 
Via Benzinga
2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Brush Off
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Insulet Corp (NASDAQ:PODD) Fits Minervini’s Trend Template with Strong Growth Momentum
Insulet Corp (PODD) aligns with Minervini's high-growth momentum strategy, showing strong technical uptrends, robust earnings growth, and solid revenue expansion. A top pick for investors seeking... 
Via Chartmill
PODD Q2 Deep Dive: Omnipod 5 Adoption and International Expansion Drive Results
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 32.9% year on year to $649.1 million. On top of that,... 
Via StockStory
Topics World Trade
Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run?
Boston Scientific stock rose to a record high in July and then consolidated. Prepping For a fresh run higher? 
Via Investor's Business Daily
Topics ETFs
Stay informed with the top movers within the S&P500 index on Thursday.
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars
Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 32.9% year on year to $649.1 million. On top of that, next quarter’s... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.